276 related articles for article (PubMed ID: 23029355)
21. ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells.
Hagan CR; Regan TM; Dressing GE; Lange CA
Mol Cell Biol; 2011 Jun; 31(12):2439-52. PubMed ID: 21518957
[TBL] [Abstract][Full Text] [Related]
22. Progesterone receptor A and B isoforms in the human breast and its disorders.
Ariga N; Suzuki T; Moriya T; Kimura M; Inoue T; Ohuchi N; Sasano H
Jpn J Cancer Res; 2001 Mar; 92(3):302-8. PubMed ID: 11267940
[TBL] [Abstract][Full Text] [Related]
23. Progesterone receptor isoform B expression in pulmonary neuroendocrine cells decreases cell proliferation.
Asavasupreechar T; Saito R; Edwards DP; Sasano H; Boonyaratanakornkit V
J Steroid Biochem Mol Biol; 2019 Jun; 190():212-223. PubMed ID: 30926428
[TBL] [Abstract][Full Text] [Related]
24. Differential hormonal regulation and function of progesterone receptor isoforms in normal adult mouse mammary gland.
Aupperlee MD; Haslam SZ
Endocrinology; 2007 May; 148(5):2290-300. PubMed ID: 17317767
[TBL] [Abstract][Full Text] [Related]
25. Differential localization and activity of the A- and B-forms of the human progesterone receptor using green fluorescent protein chimeras.
Lim CS; Baumann CT; Htun H; Xian W; Irie M; Smith CL; Hager GL
Mol Endocrinol; 1999 Mar; 13(3):366-75. PubMed ID: 10076994
[TBL] [Abstract][Full Text] [Related]
26. Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial.
Elía A; Saldain L; Vanzulli SI; Helguero LA; Lamb CA; Fabris V; Pataccini G; Martínez-Vazquez P; Burruchaga J; Caillet-Bois I; Spengler E; Acosta Haab G; Liguori M; Castets A; Lovisi S; Abascal MF; Novaro V; Sánchez J; Muñoz J; Belizán JM; Abba MC; Gass H; Rojas P; Lanari C
Clin Cancer Res; 2023 Mar; 29(5):866-877. PubMed ID: 36269797
[TBL] [Abstract][Full Text] [Related]
27. Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells.
Labriola L; Salatino M; Proietti CJ; Pecci A; Coso OA; Kornblihtt AR; Charreau EH; Elizalde PV
Mol Cell Biol; 2003 Feb; 23(3):1095-111. PubMed ID: 12529413
[TBL] [Abstract][Full Text] [Related]
28. Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptor.
McGowan EM; Russell AJ; Boonyaratanakornkit V; Saunders DN; Lehrbach GM; Sergio CM; Musgrove EA; Edwards DP; Sutherland RL
Cancer Res; 2007 Sep; 67(18):8942-51. PubMed ID: 17875737
[TBL] [Abstract][Full Text] [Related]
29. Triple SILAC identified progestin-independent and dependent PRA and PRB interacting partners in breast cancer.
Pateetin P; Hutvagner G; Bajan S; Padula MP; McGowan EM; Boonyaratanakornkit V
Sci Data; 2021 Apr; 8(1):100. PubMed ID: 33846359
[TBL] [Abstract][Full Text] [Related]
30. Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.
Mote PA; Leary JA; Avery KA; Sandelin K; Chenevix-Trench G; Kirk JA; Clarke CL;
Genes Chromosomes Cancer; 2004 Mar; 39(3):236-48. PubMed ID: 14732925
[TBL] [Abstract][Full Text] [Related]
31. Effect of initial subcellular localization of progesterone receptor on import kinetics and transcriptional activity.
Li H; Fidler ML; Lim CS
Mol Pharm; 2005; 2(6):509-18. PubMed ID: 16323958
[TBL] [Abstract][Full Text] [Related]
32. Detection of progesterone receptor forms A and B by immunohistochemical analysis.
Mote PA; Johnston JF; Manninen T; Tuohimaa P; Clarke CL
J Clin Pathol; 2001 Aug; 54(8):624-30. PubMed ID: 11477119
[TBL] [Abstract][Full Text] [Related]
33. Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas.
Wargon V; Fernandez SV; Goin M; Giulianelli S; Russo J; Lanari C
Breast Cancer Res Treat; 2011 Apr; 126(2):319-32. PubMed ID: 20440553
[TBL] [Abstract][Full Text] [Related]
34. Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium.
Arnett-Mansfield RL; DeFazio A; Mote PA; Clarke CL
J Clin Endocrinol Metab; 2004 Mar; 89(3):1429-42. PubMed ID: 15001645
[TBL] [Abstract][Full Text] [Related]
35. Developmental and hormonal regulation of progesterone receptor A-form expression in female mouse lung in vivo: interaction with glucocorticoid receptors.
Shao R; Egecioglu E; Weijdegård B; Ljungström K; Ling C; Fernandez-Rodriguez J; Billig H
J Endocrinol; 2006 Sep; 190(3):857-70. PubMed ID: 17003286
[TBL] [Abstract][Full Text] [Related]
36. Estrogen-mediated signaling is differentially affected by the expression levels of Sfrp1 in mammary epithelial cells.
Gregory KJ; Schneider SS
Cell Biol Int; 2015 Jul; 39(7):873-9. PubMed ID: 25809273
[TBL] [Abstract][Full Text] [Related]
37. Gene expression profile and cancer-associated pathways linked to progesterone receptor isoform a (PRA) predominance in transgenic mouse mammary glands.
Carlini MJ; Recouvreux MS; Simian M; Nagai MA
BMC Cancer; 2018 Jun; 18(1):682. PubMed ID: 29940887
[TBL] [Abstract][Full Text] [Related]
38. Progesterone receptor isoforms in normal and malignant breast.
Mote PA; Graham JD; Clarke CL
Ernst Schering Found Symp Proc; 2007; (1):77-107. PubMed ID: 18540569
[TBL] [Abstract][Full Text] [Related]
39. FGF2 induces breast cancer growth through ligand-independent activation and recruitment of ERα and PRBΔ4 isoform to MYC regulatory sequences.
Giulianelli S; Riggio M; Guillardoy T; Pérez Piñero C; Gorostiaga MA; Sequeira G; Pataccini G; Abascal MF; Toledo MF; Jacobsen BM; Guerreiro AC; Barros A; Novaro V; Monteiro FL; Amado F; Gass H; Abba M; Helguero LA; Lanari C
Int J Cancer; 2019 Oct; 145(7):1874-1888. PubMed ID: 30843188
[TBL] [Abstract][Full Text] [Related]
40. The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer.
Sequeira G; Vanzulli SI; Rojas P; Lamb C; Colombo L; May M; Molinolo A; Lanari C
Oncotarget; 2014 May; 5(10):3246-60. PubMed ID: 24912774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
